HT
AVXL icon

HAP Trading’s Anavex Life Sciences AVXL Stock Holding History

HAP Trading’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,500
Closed -$1.88K – 1040
2023
Q2 		$1.88K Sell
12,500
-3,900
-24% -$33.4K ﹤0.01% 1005
2023
Q1 		$8K Sell
16,400
-22,700
-58% -$227K ﹤0.01% 914
2022
Q4 		$33K Sell
39,100
-1,800
-4% -$19.2K ﹤0.01% 840
2022
Q3 		$71K Sell
40,900
-10,400
-20% -$110K ﹤0.01% 886
2022
Q2 		$70K Sell
51,300
-12,400
-19% -$117K ﹤0.01% 976
2022
Q1 		$82K Buy
63,700
+42,900
+206% +$528K ﹤0.01% 1117
2021
Q4 		$31K Buy
20,800
+700
+3% +$13.3K ﹤0.01% 1661
2021
Q3 		$30K Sell
20,100
-17,800
-47% -$354K ﹤0.01% 1672
2021
Q2 		$225K Buy
37,900
+400
+1% +$5.92K 0.01% 961
2021
Q1 		$176K Buy
37,500
+16,100
+75% +$176K 0.01% 798
2020
Q4 		$12K Buy
21,400
+7,400
+53% +$39K ﹤0.01% 1854
2020
Q3 		$15K Buy
+14,000
New +$60.3K ﹤0.01% 1229
2017
Q2 		– Sell
-14,100
Closed -$5K – 940
2017
Q1 		$5K Buy
+14,100
New +$72.8K ﹤0.01% 952

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HAP Trading's AVXL Position: Q4 2021 in Review

HAP Trading sold out of Anavex Life Sciences (AVXL) in Q4 2021, closing a stake of 27,871 shares — an estimated $530K sold.

HAP Trading first reported a position in AVXL in Q3 2021 and held it in 1 quarter. The position peaked at $500K in Q3 2021. 149 funds tracked by Wall St. Rank hold AVXL as of Q4 2021.

  • HAP Trading reported no remaining Anavex Life Sciences position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 27,871 Anavex Life Sciences shares in Q4 2021, an estimated $530K.
  • HAP Trading first reported a position in Anavex Life Sciences in Q3 2021 and held it in 1 quarter.
  • HAP Trading's Anavex Life Sciences position peaked at $500K in Q3 2021.
  • 149 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.